AnaptysBio Total Stockholder Equity from 2010 to 2025
| ANAB Stock | USD 18.65 0.46 2.53% |
Total Stockholder Equity | First Reported 2013-12-31 | Previous Quarter 84.4 M | Current Value 70.9 M | Quarterly Volatility 165.9 M |
Check AnaptysBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnaptysBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 52.6 M or Selling General Administrative of 44.5 M, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0 or PTB Ratio of 7.69. AnaptysBio financial statements analysis is a perfect complement when working with AnaptysBio Valuation or Volatility modules.
AnaptysBio | Total Stockholder Equity |
Latest AnaptysBio's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of AnaptysBio over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. AnaptysBio's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AnaptysBio's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
AnaptysBio Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 158,043,100 | |
| Geometric Mean | 22,447,912 | |
| Coefficient Of Variation | 111.93 | |
| Mean Deviation | 158,244,675 | |
| Median | 70,868,000 | |
| Standard Deviation | 176,893,249 | |
| Sample Variance | 31291.2T | |
| Range | 486.2M | |
| R-Value | 0.43 | |
| Mean Square Error | 27453.2T | |
| R-Squared | 0.18 | |
| Significance | 0.10 | |
| Slope | 15,813,635 | |
| Total Sum of Squares | 469368.3T |
AnaptysBio Total Stockholder Equity History
About AnaptysBio Financial Statements
AnaptysBio stakeholders use historical fundamental indicators, such as AnaptysBio's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although AnaptysBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in AnaptysBio's assets and liabilities are reflected in the revenues and expenses on AnaptysBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AnaptysBio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 70.9 M | 67.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of AnaptysBio Correlation against competitors. For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share | Quarterly Revenue Growth 3.788 | Return On Assets | Return On Equity |
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.